Landscapes / Targets
thrombopoietin receptor
5 drugs act on thrombopoietin receptor, in 8 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs5
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved | 30 Jun 2028Phase 2/3 trial completes | |||
| Next date | 30 Jun 2028 · Phase 2/3 trial completes | ||||
| Also tested for | Aplastic Anemia | ||||
| Open drug page | |||||
— |
Hengrui · Public 600276.SS |
Approved in China | Dec 2028Phase 3 trial completes | ||
| Next date | Dec 2028 · Phase 3 trial completes | ||||
| Also tested for | Chemotherapy-Induced Thrombocytopenia, Patients With Chemotherapy-Induced Thrombocytopenia | ||||
| Open drug page | |||||
Thrombopoietin receptor agonist |
Amgen · Public AMGN |
Approved | 14 Sep 2029Phase 3 trial completes | ||
| Next date | 14 Sep 2029 · Phase 3 trial completes | ||||
| Also tested for | Chemotherapy-induced Thrombocytopenia, Primary Immune Thrombocytopenia | ||||
| Open drug page | |||||
— |
Phase 3 | 30 Apr 2027Phase 2/3 trial completes | |||
| Next date | 30 Apr 2027 · Phase 2/3 trial completes | ||||
| Also tested for | Cancer Treatment-Induced Thrombocytopenia, Thrombocytopenia, Immune | ||||
| Open drug page | |||||
GP40141not checked |
— |
Phase 3 | 31 Mar 2028Phase 3 trial completes | ||
| Next date | 31 Mar 2028 · Phase 3 trial completes | ||||
| Also tested for | Drug Effect, Safety Issues and 1 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 4 of 5 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026